Latest Breaking News On - Hall james - Page 20 : comparemela.com

Riverbridge Partners LLC Has $45 56 Million Stake in GoDaddy Inc (NYSE:GDDY)

Riverbridge Partners LLC decreased its holdings in GoDaddy Inc. (NYSE:GDDY – Free Report) by 20.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 429,130 shares of the technology company’s stock after selling 108,011 shares during the quarter. Riverbridge Partners LLC owned 0.30% of […]

United statesRobertw bairdAmanpal singh bhutaniRaymond jamesRoger chenSecurities exchange commissionPacer advisors incRiverbridge partnersHorrell capital management incSg americas securitiesGodaddy incBleakley financial groupJpmorgan chase coGodaddy company profileRice hall james associatesWoocommerce stores

GoDaddy (NYSE:GDDY) Given New $136 00 Price Target at JPMorgan Chase & Co

GoDaddy (NYSE:GDDY) Given New $136 00 Price Target at JPMorgan Chase & Co
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRaymond jamesNick daddarioAmanpal singh bhutaniJpmorgan chase coGodaddy incRoyal bankWoocommerce storesMetlife investment managementRice hall james associatesSecurities exchange commissionHightower advisorsRaymond james trustFree reportModerate buyGet free report

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3 2%

Y-mAbs Therapeutics (NASDAQ:YMAB) Shares Down 3 2%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesCanaccord genuity groupY mabs therapeutics company profileRice hall james associatesSwiss national bankJpmorgan chase coMetlife investment managementY mabs therapeutics incBlackrock incY mabs therapeuticsGet free reportGenuity groupAbs therapeuticsHall jamesNational bankLife investment management

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Receives Consensus Rating of Buy from Analysts

BioCryst Pharmaceuticals, Inc (NASDAQ:BCRX) Receives Consensus Rating of Buy from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News ratings for biocryst pharmaceuticals dailyBiocryst pharmaceuticals incDeerfield management companylp seriesAnalyst recommendations for biocryst pharmaceuticalsRice hall james associatesBiocryst pharmaceuticals company profileBiocryst pharmaceuticals stock performanceHedge funds weigh in on biocryst pharmaceuticalsBiocryst pharmaceuticalsJump financialNeedham companyGet free reportCryst pharmaceuticalsCapital managementRice hall jamesHall james

Trust Point Inc Takes Position in Chemed Co (NYSE:CHE)

Trust Point Inc. acquired a new stake in shares of Chemed Co. (NYSE:CHE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,976 shares of the company’s stock, valued at approximately $2,325,000. Several other institutional investors and hedge […]

United statesSpencers leeBrianc judkinsPanagora asset management incSecurities exchange commissionPoint incRice hall james associatesChemed corporationHightower advisorsRoyal bankChemed coExchange commissionAmerican century companies incRaymond james financial services advisors incTrust pointFree report